Technology | 2014.03.11
TriVascular Technologies, Inc. Files Registration Statement for Proposed Initial Public Offering
TriVascular Technologies, Inc. (TriVascular), manufacturer of the Ovation Prime® Abdominal Stent Graft System, today announced that is has filed a registration statement on Form S-1 with the Securities and Exchange Commission relating to a proposed initial public offering of shares of its common stock.
(PRWeb March 10, 2014)
Read the full story at http://www.prweb.com/releases/2014/03/prweb11656068.htm
For more information, please visit
http://www.prweb.com/releases/2014/03/prweb11656068.htm
